Paratek Pharmaceuticals
formerly Paratek (formerly Transcept Pharmaceuticals)Positive outcomes. Positive Patient Stories
Boston, United States · Founded 1996 · $1.8B raised
- Headquarters
- Boston, Massachusetts
- Employees
- 201–500
- Founded
- 1996
- Business Model
- B2B
- Website
- paratekpharma.com
- Total Funding
- $1.8B
- Last Round
- $1.6B Venture RoundApr 2018
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Paratek Pharmaceuticals develops and commercializes specialty therapies for patients with infectious diseases and other difficult-to-treat conditions. Its FDA-approved portfolio includes NUZYRA (omadacycline), a tetracycline-class antibiotic for adult community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections, and XHANCE, a prescription nasal spray for chronic rhinosinusitis with or without nasal polyps. The company aims to be a leading independent pharmaceutical firm providing innovative specialty therapies that address life-threatening infections and complex medical needs.
Summary
Paratek Pharmaceuticals is a Biotech company based in Boston, United States, founded in 1996. It has raised $1.8B in total across 3 rounds, most recently a $1.6B Venture Round in Apr 2018. Investors include Novo Holdings A/S, Gurnet Point Capital and REPAIR Impact Fund (Novo Holdings).
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2023
Sign up to see all 7 events
Funding: Series C through Convertible Note. Amounts, valuations, and investors where available.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/paratek-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/paratek-pharmaceuticals" alt="Paratek Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>